PL412941A1 - Preparat na zmarszczki - Google Patents
Preparat na zmarszczkiInfo
- Publication number
- PL412941A1 PL412941A1 PL412941A PL41294115A PL412941A1 PL 412941 A1 PL412941 A1 PL 412941A1 PL 412941 A PL412941 A PL 412941A PL 41294115 A PL41294115 A PL 41294115A PL 412941 A1 PL412941 A1 PL 412941A1
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- wrinkles
- weight
- propolis
- amount
- Prior art date
Links
- 230000037303 wrinkles Effects 0.000 title abstract 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
- 241000241413 Propolis Species 0.000 abstract 2
- 229940069949 propolis Drugs 0.000 abstract 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 abstract 1
- WBTFUMUXXHWTLD-UHFFFAOYSA-N 4-phenoxybutan-2-ol Chemical compound CC(O)CCOC1=CC=CC=C1 WBTFUMUXXHWTLD-UHFFFAOYSA-N 0.000 abstract 1
- 229920002385 Sodium hyaluronate Polymers 0.000 abstract 1
- 229940100524 ethylhexylglycerin Drugs 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 235000019271 petrolatum Nutrition 0.000 abstract 1
- 229940010747 sodium hyaluronate Drugs 0.000 abstract 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 abstract 1
- 229940099259 vaseline Drugs 0.000 abstract 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Preparat na zmarszczki zawiera: wazelinę farmaceutyczną, olej wazelinowy, wosk, ekstrakt glikolowy z propolisu, 1% roztwór hialuronianu sodowego, fenoksyetyloetanol, etyloheksyloglicerynę. Preparat charakteryzuje się tym, że zawiera propolis w ilości 4% wagowych oraz kwas hialuronowy w ilości 1% wagowych.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL412941A PL412941A1 (pl) | 2015-06-30 | 2015-06-30 | Preparat na zmarszczki |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL412941A PL412941A1 (pl) | 2015-06-30 | 2015-06-30 | Preparat na zmarszczki |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL412941A1 true PL412941A1 (pl) | 2017-01-02 |
Family
ID=57629172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL412941A PL412941A1 (pl) | 2015-06-30 | 2015-06-30 | Preparat na zmarszczki |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL412941A1 (pl) |
-
2015
- 2015-06-30 PL PL412941A patent/PL412941A1/pl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276016B (en) | Ocular formulations for administration of drug to the back of the eye | |
| CL2016000882A1 (es) | Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15). | |
| ECSP17078433A (es) | Composiciones de ácido obeticólico y métodos de uso | |
| CO2019000613A2 (es) | 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2 | |
| MX2019003364A (es) | Composiciones oftalmicas que comprenden ciclosporina. | |
| EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| EA201691988A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| MX388893B (es) | Formulaciones de anticuerpos estables acuosas. | |
| UY37098A (es) | Moduladores de ror-gamma | |
| BR112018075140A2 (pt) | composição na forma de uma solução aquosa injetável, e, formulação de dose única a um ph de 7 a 7,8 | |
| EA201692526A1 (ru) | Замещенные [1,2,4]триазольные соединения | |
| MX372988B (es) | Composiciones oftalmicas estabilizadas de omega 3. | |
| MX378866B (es) | Composiciones de azucar para la formacion de comprimidos por compresion directa. | |
| BR112016022394A2 (pt) | Composição farmaceuticamente aceitável, composição na forma de uma solução injetável farmaceuticamente aceitável, uso da composição, e, método para a preparação da composição injetável farmaceuticamente aceitável | |
| MX377302B (es) | Composiciones para el cuidado personal con dos fases benéficas. | |
| MX2020003049A (es) | Semaglutida en la terapia medica. | |
| UY36460A (es) | Pirazolpiridinaminas | |
| CR20150653A (es) | Compuestos nuevos para el tratamiento del cáncer | |
| MX2017000829A (es) | Composiciones de azucares para la formacion de comprimidos mediante compresion directa. | |
| MX2017003550A (es) | Uso de cisteamina en tratamiento de infecciones causadas por levaduras/mohos. | |
| MX390448B (es) | Composicion adhesiva. | |
| IN2013MU03773A (pl) | ||
| WO2014097258A3 (en) | Aqueous cosmetic composition comprising alkylcellulose | |
| CL2014002729A1 (es) | Composicion farmaceutica conformada por baba de caracol helix aspersa müller (20-50%), extracto de manzanilla (1-4%), propoleo (1-4%) y aditivos y/o excipientes, con una viscosidad de 10 a 1000 pa-s, en forma de locion, crema, jabon o gel; procedimiento para obtenerla; y su uso para prevenir o tratar patologias de la rosacea. | |
| EA201892157A1 (ru) | Фосфаплатиновые жидкие составы |